The pharmacokinetics of milrinone in pediatric patients after cardiac surgery

Anesthesiology

Volumn 90, Issue 4, 1999, Pages 1012-1018

  Bailey, James M ^a   Miller, Bruce E ^b   Lu, Wei ^b   Tosone, Steven R ^b   Kanter, Kirk R ^b   Tam, Vincent K H ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Congenital heart disease; Pharmacokinetics; Phosphodiesterase inhibitors

Indexed keywords

FENTANYL; HALOTHANE; ISOFLURANE; MIDAZOLAM; MILRINONE; PHOSPHODIESTERASE INHIBITOR;

AGE; ARTICLE; BODY WEIGHT; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; COMPARTMENT MODEL; CONGENITAL HEART MALFORMATION; CONTINUOUS INFUSION; CONTROLLED STUDY; DISTRIBUTION VOLUME; DOSE CALCULATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; HEART HEMODYNAMICS; HEART INDEX; HEART OUTPUT; HEART SURGERY; HUMAN; INFANT; MEAN ARTERIAL PRESSURE; PRESCHOOL CHILD; PRIORITY JOURNAL;

EID: 0032902453     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199904000-00014     Document Type: Article

References (16)

1. Colucci WS, Wright RF, Braunwald E: New positive inotropic agents in the treatment of congestive heart failure: Mechanism of action and recent clinical developments. 2. N Engl J Med 1986; 314: 349-58
2. Evans DR: Overview of cardiovascular physiologic and pharmacologic aspects of selective phosphodiesierase peak III inhibitors. Am J Cardiol 1989; 63:9A-11A
3. Levy JH, Ramsay J, Bailey JM: Pharmacokinetics and pharmacodynamics of phosphodiesterase-III inhibitors. J Cardiothoracic Anesth 1990; 4(Suppl 5):7-11
4. Fita G, Gomar C, Jimencz MJ, Pacheco M, Mulet J, Nalda MA: Amrinone in perioperative low cardiac output syndrome. Acta Anaesthesiol Scand 1990; 34:482-5
5. Fenecek RO: Effects of variable dose milrinone in patients with low cardiac output after cardiac surgery. Am Heart J 1991; 121: 1995-9
6. Bailey JM, Levy JH, Kikura M, Szlam F, Hug CC Jr: Pharmacokinetics of intravenous milrinone in patients undergoing cardiac surgery. ANESTHESIOLOGY 1994; 81:616-22
7. Kikura M, Lee MK, Safon RA, Bailey JM, Levy JH: The effects of milrinone on platelets in patients undergoing cardiac surgery. Anesth Analg 1995; 81:44-8
8. Lawless S, Burkhart G, Diven W, Thompson A, Siewers R: Amrinone in neonates and infants after cardiac surgery. Crit Care Med 1989; 17:751-4
9. Sorensen GK, Ramamoorthy C, Lynn AM, Anderson GD, Opheim KE: Hemodynamic effects of amrinone and colloid administration in children following cardiac surgery. J Cardiothorac Anesth 1993; 7:560-5
10. Bailey JM, Miller BE, Kanter KR, Tosone SR, Tarn VKH: A comparison of the hemodynamic effects of amrinone and sodium nitroprusside in infants after cardiac surgery. Anesth Analg 1997; 84:294-8
11. Chang AC, Atz AM, Wernovsky G, Burke RP, Wessel DL: Milrinone: Systemic and pulmonary hemodynamic effects after cardiac surgery. Crit Care Med 1995; 23:1907-14
12. Barton P, Garcia J, Koutali A, Kitchen L, Zorka A, Lindsay C, Lawless S, Giroir B: Hemodynamic effects of IV milrinone lactate in pediatric patients with septic shock. Chest 1996; 109:1302-12
13. Sheiner LB, Rosenberg B, Marathe VV: Estimation of population characteristics of pharmacokinetic parameters from routine clinical data. J Pharmacokinet Biopharm 1977; 5:445-79
14. Kataria BK, Ved SA, Nicodemus HF, Hoy GR, Lea D, Dubois MY, Mandema JW, Shafer SL: The pharmacokinetics of propofol in children using three different data analysis approaches. ANESTHESIOLOGY 1994; 80:104-22
15. Ramamoorthy C, Anderson GD, Williams GD, Lynn AM: Pharmacokinetics and side effects of milrinone in infants and children after open heart surgery. Anesth Analg 1998; 86:283-9
16. Bailey JM: A technique for approximately maintaining constant plasma levels of intravenous drugs. ANESTHESIOLOGY 1993; 78:116-23